BEAM vs CRSP
BEAM 与 CRSP 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | BEAMBeam Therapeutics Inc. | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| 市值 | $2.84B | $5.00B |
| 市净率 | 2.98 | — |
| 市销率 | 20.5x | 1437.0x |
| 营收 | $146.64M(TTM) | — |
| 营收同比增长 | 120.0% | -90.6% |
| 净利润 | -$108.35M(TTM) | — |
| 净利同比增长 | 78.8% | -58.8% |
| 每股收益(稀释) | $-0.88(TTM) | — |
| 息税前利润率 | -274.6% | -18933.6% |
| 净资产收益率 | -8.4% | -35.3% |
| 投入资本回报率 | -45.7% | -32.5% |
| 一年总回报 | +21.6% | -7.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:BEAM vs CRSP
| 指标 | BEAM | CRSP |
|---|---|---|
| 期末价值 | $14.6K | $9.5K |
| 总回报 | +46.1% | -5.2% |
| 年化收益 (CAGR) | +5.8% | -0.8% |
| 波动率 | 79.5% | 61.5% |
| 夏普比率 | 0.41 | 0.22 |
| 索提诺比率 | 0.63 | 0.34 |
| 最大回撤 | -89.1% | -85.1% |
基于 1696 个共同交易日,2020-02-06 → 2026-11-04 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)